Comparison of two shoulder replacement methods after trauma

ISRCTN ISRCTN21981284
DOI https://doi.org/10.1186/ISRCTN21981284
Secondary identifying numbers Protocol 1.9
Submission date
13/01/2015
Registration date
27/01/2015
Last edited
03/12/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Injuries to the shoulder joint are common and occur more frequently in elderly patients who fall from standing height. In more severe breaks to the shoulder joint an operation can be performed to prevent pain and deformity. This is often done by replacing the broken head of the joint with a metal ball known as a hemiarthroplasty (shoulder replacement). There is growing debate about the most appropriate treatment of these injuries. There is a newer implant called a reverse total shoulder replacement in which, in addition to replacing the head, the socket is replaced in the shoulder joint. This reverse polarity shoulder replacement has been growing in popularity for treating these injuries. This study compares the results of hemiarthroplasty and reverse total shoulder replacement in severely broken shoulder joints to guide future treatment.

Who can participate?
Adults aged at least 65 years who sustained a severely broken shoulder joint within the last three weeks.

What does the study involve?
Participants are randomly allocated into one of two groups. All participants have shoulder replacement surgery but those in group 1 have a hemiarthoplasty and those in group 2 have a reverse total shoulder replacement. Participants are not told what type of replacement they are having. After surgery, both groups of participants are treated with immobilisation in a sling for four weeks followed by physiotherapy. All participants are seen at six weeks, three months, one year and two years, when they are asked to complete a questionnaire and have an examination. X-rays are also routinely taken during return visits.

What are the possible benefits and risks of participating?
The major benefits of having surgery is that provides good pain relief and function of the shoulder joint for both groups of participants. All the surgical procedures are performed under general anaesthetic. Although anaesthesia is extremely safe with modern techniques, there are still very small risks involved. Some people experience nausea, vomiting and/or dizziness. These are reduced with modern drugs. It is important that participants tell the research team about any medical problems. The surgical procedure itself carries some risks including dislocation of the joint and possibility of further breaks in the bone. There is a small chance of developing wound infection. This may require treatment with antibiotics. There is also a small risk of damage to the adjacent nerves and vessels in the shoulder.

Where is the study run from?
The study is being run from multiple orthopaedic centres in the UK who are experienced in both the management of these injuries and conducting studies of this kind.

When is the study starting and how long is it expected to run for?
June 2013 to May 2019

Who is funding the study?
Tornier UK Limited (UK)

Who is the main contact?
Professor A C Watts

Contact information

Prof Adam Watts
Public

Wrightington Hospital
Hall Lane
Appley Bridge
Wigan
Lancashire
WN6 9EP
United Kingdom

Study information

Study designMulticentre randomised controlled interventional trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleShoulder Hemiarthroplasty versus Reverse Total Shoulder Arthroplasty for Trauma
Study acronymSHeRPA
Study hypothesisThere is no difference in outcome at one year for proximal humerus fractures treated with hemiarthroplasty or reverse shoulder arthroplasty.
Ethics approval(s)National Research Ethics Committee (REC) North West – Greater Manchester West, 07/05/2013, ref: 12/NW/0724
Condition3 or 4 part proximal humerus fractures
Intervention1. Proximal humerus hemiarthroplasty (intervention 1)
2. Reverse polarity total shoulder arthroplasty (intervention 2)
Intervention typeProcedure/Surgery
Primary outcome measureDifference in the mean Constant Score at 12 months post-operatively
Secondary outcome measuresDifference in the mean Constant score, quickDASH score, Oxford shoulder score and ASES score at two years post-operatively
Overall study start date05/06/2013
Overall study end date01/05/2019

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participantsFifty (50) patients
Participant inclusion criteriaA patient over the age of 65 years within three weeks of a three or four part proximal humerus fracture and who is fit for surgical intervention
Participant exclusion criteria1. Dementia
2. Refusal of consent
3. Patient unfit for reverse polarity arthroplasty
4. Glenoid fracture
5. Axillary nerve palsy
Recruitment start date01/08/2013
Recruitment end date01/05/2017

Locations

Countries of recruitment

  • England
  • Scotland
  • United Kingdom

Study participating centres

Wrightington Wigan and Leigh NHS Trust
Hall Lane
Appley Bridge
Wigan
WN8 9EP
United Kingdom
Royal Devon and Exeter NHS Foundation Trust
Barrack Road
Exeter
Devon
EX2 5DW
United Kingdom
Frenchay Hospital, North Bristol NHS Trust
Frenchay Park Road
Bristol
BS16 1LE
United Kingdom
York Teaching Hospitals NHS Foundation Trust
Wigginton Road
York
North Yorkshire
YO31 8HE
United Kingdom
Glasgow Royal Infirmary
84 Castle Street
Glasgow
G4 0SF
United Kingdom

Sponsor information

Wrightington Hospital
Hospital/treatment centre

Research and Development
Hall Lane
Appley Bridge
Wigan
Lancashire
WN6 9EP
England
United Kingdom

ROR logo "ROR" https://ror.org/00y112q62

Funders

Funder type

Industry

Tornier UK Limited

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination plan
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

On 03/12/2015 the following changes were made to the trial record:
1. The recruitment end date was changed from 31/07/2015 to 01/05/2017.
2. The overall trial end date was changed from 01/08/2017 to 01/05/2019.